MedTrace Logo

ABSORB EXTEND Clinical Investigation

NCT01023789 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 812

Last updated 2018-02-14

Study results available
· View outcomes & findings →

Summary

The ABSORB EXTEND trial is to continue the assessment of the safety and performance of the ABSORB Bioresorbable Vascular Scaffold (BVS) System

ABSORB BVS is currently in development at Abbott Vascular.

Conditions

Interventions

DEVICE

ABSORB BVS

Absorb Bioresorbable Vascular Scaffold (BVS) System implantation

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Alexandre Abizaid, MD · Instituto de Cardiologia Dante Pazzanese Unidadae II Recepcao de Angioplastia

  • Patrick Serruys, MD · Thoraxcenter-Erasmus University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • China
  • Denmark
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Japan
  • Malaysia
  • Netherlands
  • New Zealand
  • Poland
  • Singapore
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01023789 on ClinicalTrials.gov